Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation

We present two cases of women who suffered from neurotrophic keratopathy (one of them had undergone penetrating keratoplasty) which had led to corneal thinning. Tachosil(®) was used as an adjuvant treatment after topical medication by itself failed in both cases. To our knowledge, there are no repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahhal-Ortuño, Miriam, Fernández-Santodomingo, Alex S, Molina-Pallete, Rodrigo D, Hurtado-Sarrió, Mercedes, Cisneros-Lanuza, Ángel L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611324/
https://www.ncbi.nlm.nih.gov/pubmed/31238463
http://dx.doi.org/10.4103/ijo.IJO_1573_18
_version_ 1783432673905082368
author Rahhal-Ortuño, Miriam
Fernández-Santodomingo, Alex S
Molina-Pallete, Rodrigo D
Hurtado-Sarrió, Mercedes
Cisneros-Lanuza, Ángel L
author_facet Rahhal-Ortuño, Miriam
Fernández-Santodomingo, Alex S
Molina-Pallete, Rodrigo D
Hurtado-Sarrió, Mercedes
Cisneros-Lanuza, Ángel L
author_sort Rahhal-Ortuño, Miriam
collection PubMed
description We present two cases of women who suffered from neurotrophic keratopathy (one of them had undergone penetrating keratoplasty) which had led to corneal thinning. Tachosil(®) was used as an adjuvant treatment after topical medication by itself failed in both cases. To our knowledge, there are no reported cases of the use of Tachosil(®) in corneal grafts.
format Online
Article
Text
id pubmed-6611324
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66113242019-07-22 Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation Rahhal-Ortuño, Miriam Fernández-Santodomingo, Alex S Molina-Pallete, Rodrigo D Hurtado-Sarrió, Mercedes Cisneros-Lanuza, Ángel L Indian J Ophthalmol Case Reports We present two cases of women who suffered from neurotrophic keratopathy (one of them had undergone penetrating keratoplasty) which had led to corneal thinning. Tachosil(®) was used as an adjuvant treatment after topical medication by itself failed in both cases. To our knowledge, there are no reported cases of the use of Tachosil(®) in corneal grafts. Wolters Kluwer - Medknow 2019-07 /pmc/articles/PMC6611324/ /pubmed/31238463 http://dx.doi.org/10.4103/ijo.IJO_1573_18 Text en Copyright: © 2019 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Reports
Rahhal-Ortuño, Miriam
Fernández-Santodomingo, Alex S
Molina-Pallete, Rodrigo D
Hurtado-Sarrió, Mercedes
Cisneros-Lanuza, Ángel L
Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
title Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
title_full Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
title_fullStr Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
title_full_unstemmed Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
title_short Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
title_sort use of tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611324/
https://www.ncbi.nlm.nih.gov/pubmed/31238463
http://dx.doi.org/10.4103/ijo.IJO_1573_18
work_keys_str_mv AT rahhalortunomiriam useoftachosilasanadjuvanttherapeuticoptioninneurotrophickeratopathyinordertopreventperforation
AT fernandezsantodomingoalexs useoftachosilasanadjuvanttherapeuticoptioninneurotrophickeratopathyinordertopreventperforation
AT molinapalleterodrigod useoftachosilasanadjuvanttherapeuticoptioninneurotrophickeratopathyinordertopreventperforation
AT hurtadosarriomercedes useoftachosilasanadjuvanttherapeuticoptioninneurotrophickeratopathyinordertopreventperforation
AT cisneroslanuzaangell useoftachosilasanadjuvanttherapeuticoptioninneurotrophickeratopathyinordertopreventperforation

Ejemplares similares